ACTRN12609000904279
Recruiting
Phase 2
Study of molecular changes induced by treatment with bevacizumab in metastatic breast cancer
Georgios Kesisis0 sites40 target enrollmentOctober 19, 2009
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- metastatic breast cancer
- Sponsor
- Georgios Kesisis
- Enrollment
- 40
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •histologically proven metastatic breast cancer, locally accessible disease (breast tumor, skin mets, lymph node mets), Performance status (PS) 0\-1, normal liver and kidney function
Exclusion Criteria
- •history of thrombotic disease, uncontrolled brain metastases, pregnancy, lactation, prior bevacizumab exposure, recent surgery (within 4 weeks), active bleeding, active infection, unhealed wound, use of anticoagulants in therapeutic doses
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Prospective Evaluation of the Molecular Effects of Itraconazoleas an anti-cancer agent: A Window of Opportunity Studysolid tumorsJPRN-UMIN000018388Hyogo College of Medicine20
Recruiting
Phase 2
Window trialJPRN-jRCTs051190006Tsubamoto Hiroshi200
Recruiting
Phase 4
HeberproGen StudyDiabetic foot ulcers.RPCEC00000117Center for Genetic Engineering and Biotechnology (CIGB).156
Recruiting
Not Applicable
Effect of a Diet with fewer Calories and a low-Meat diet in the metabolism of humansType 2 Diabetes MellitusC18.452.394.750.149RBR-3hknrwHospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da USP
Completed
Not Applicable
A study on the effects of application of compounded stenone cream (fermented product enriched with plant stenones) on subcutaneous fat and visceral fat.Healthy adultsJPRN-UMIN000039249imeQ RD inc.30